• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Wall Street Beat

Collecting purposeful data in the era of connected health devices

February 16, 2017 By Sarah Faulkner

Collecting purposeful data in the era of connected health devices

Connectivity, one of the newest buzzwords in the medical device lexicon, is becoming more and more integral to device design and development. Research shows that connected health devices can improve patient outcomes by increasing adherence and reducing dosing variability. Mark David Tuckwell, head of electronics, software & systems at Sagentia, says connected device can also provide crucial information to help […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Adherium, Baxter International, Becton Dickinson, Companion Medical, GlaxoSmithKline plc, Propeller Health, Sagentia, Sanofi-Aventis

Catalent acquires soft-gel manufacturer Accucaps

February 16, 2017 By Sarah Faulkner

Catalent

Catalent (NYSE:CTLT) said today that it closed its acquisition of Canada-based Accucaps and its pharmaceutical soft-gel manufacturing capabilities. The Somerset, N.J.-based company did not disclose the deal’s financial details. In November last year, Catalent said that it planned to fund the Accucaps buy with a $400 million debt offering. The company also plans to use the private placement […]

Filed Under: Featured, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat Tagged With: Accucaps, Catalent

Biostage prices $8m offering for bioengineered organ implant

February 15, 2017 By Sarah Faulkner

Biostage prices $8m offering for bioengineered organ implants

Biostage (NSDQ:BSTG), a 27-person biotech based in Holliston, Mass., is developing technology to regrow esophageal tissue in patients that have esophageal cancer or atresia. Last week, the company priced a public offering at ¢40 per share of common stock, expecting to bring in $8 million from the round. The current standard of care for resectable […]

Filed Under: Featured, Funding Roundup, Regenerative Medicine, Wall Street Beat Tagged With: Biostage

Pfizer appeals $107m fine for anti-epilepsy drug prices in UK

February 15, 2017 By Sarah Faulkner

Pfizer

Pfizer (NYSE:PFE) and Flynn Pharma have appealed the record $107 million (£84.2 million) and $6.5 million (£5.2 million) fines imposed by the U.K. Competition & Markets Authority in December for the companies’ massive price hikes to their unbranded versions of anti-epilepsy drug Epanutin. In its appeal, Pfizer claims that the regulator did not consider market realities when […]

Filed Under: Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: Flynn Pharma, Pfizer Inc.

PharmaJet expands needle-free delivery of influenza vaccines

February 15, 2017 By Sarah Faulkner

PharmaJet

PharmaJet said today that a trivalent and quadrivalent influenza vaccine is available with its Stratis needle-free injector for this year’s flu season. PharmaJet’s device is designed to administer medication intramuscularly or subcutaneously, without the use of needles. The Chicago-based company touts the technology as a way to prevent cross-contamination between needles and enhance patient compliance. “The addition […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: PharmaJet

ICU Medical touts dosing errors study

February 15, 2017 By Sarah Faulkner

ICU Medical

ICU Medical (NSDQ:ICUI) said today that a multi-hospital study showed improvements in potentially catastrophic dosing errors and drug library compliance when its Plum infusion pumps and Hospira (NYSE:HSP) MedNet safety software were integrated with the hospitals’ electronic medical records. The rate of potentially catastrophic dosing errors fell by 52% after smart-pump EMR integration, the study found, […]

Filed Under: Featured, Hospital Care, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: Hospira Inc., ICU Medical, Pfizer Inc.

Early collaboration is key in drug-device development, experts say

February 15, 2017 By Sarah Faulkner

Industry leaders talk partnerships, collaboration in drug delivery

While pharmaceutical companies and medical device firms know that working together is a vital part of doing business, they “live in 2 different world in many ways,” Minnetronix co-founder Dirk Smith said last week at the annual Drug Delivery Partnerships conference. From development timelines to regulatory approval pathways, it can sometimes seem like pharma and medtech companies are […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Baxter International, Becton Dickinson, GlaxoSmithKline plc, Minnetronix, Sanofi-Aventis

B. Braun, Iatric Systems integrate Outlook infusion pump, Accelero Connect software

February 14, 2017 By Sarah Faulkner

B. Braun

B. Braun Medical said today that it integrated its Outlook large-volume infusion pump with Iatric Systems‘ Accelero Connect integration software. The technology enables the pump to communicate with electronic health record systems, such as Meditech. Bethlehem, Pa.-based B. Braun said it used Integrating the Healthcare Enterprise standard communication protocols and transactions to support the integration. […]

Filed Under: Drug-Device Combinations, Featured, Technology, Wall Street Beat Tagged With: B. Braun Medical, Iatric Systems

Valeant, Ackman agree to split costs in shareholders class action

February 14, 2017 By Sarah Faulkner

Valeant Pharmaceuticals

Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) and William Ackman’s hedge fund Pershing Square Capital Management reportedly agreed to split litigation costs in a class action lawsuit brought on by shareholders over an alleged insider trading scheme in Allergan (NYSE:AGN)’s 2014 takeover bid. In June 2014, Valeant offered a tender bid for Allergan, which was followed by a 7 […]

Filed Under: Legal News, Wall Street Beat Tagged With: Actavis, Allergan, Valeant Pharmaceuticals

Titan Pharmaceutical’s match-sized implant fights back against opioid addiction

February 14, 2017 By Sarah Faulkner

Titan Pharmaceuticals

The ongoing opioid crisis in the U.S. is harrowing – 91 Americans die every day from an opioid overdose, according to the Centers for Disease Control & Prevention. Companies are searching for innovative ways to deliver opioid maintenance treatment to patients that are hoping to get clean. Buprenorphine is a compound used for medication-assisted treatment, traditionally administered […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Wall Street Beat Tagged With: Centers for Disease Control & Prevention, Massachusetts Institute of Technology, Titan Pharmaceuticals

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 176
  • Page 177
  • Page 178
  • Page 179
  • Page 180
  • Interim pages omitted …
  • Page 193
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS